Cover Image
Market Research Report

Malaysia Pharmaceuticals & Healthcare Q1 2019

Published by Fitch Solutions, Inc. Product code 179529
Published Content info 70 Pages
Delivery time: 1-2 business days
Back to Top
Malaysia Pharmaceuticals & Healthcare Q1 2019
Published: December 4, 2018 Content info: 70 Pages

Key View:

We maintain a modest growth outlook for the Malaysian pharmaceutical market which will gradually slow over our forecast period as government policies continue to repress medicine sales. Innovative drug demand will be largely driven by the unmet need for non-communicable disease treatments and the government's commitment to healthcare. However, concerns over the price of pharmaceuticals and their net impact on total expenditure will see the government continue to intervene and establish drug price controls to achieve better transparency and cost efficiency in the procurement of medicines.

Table of Contents
Product Code: SSMY03_20190101

Table of Contents

Key View


Industry Forecast

  • Pharmaceutical Market Forecast
  • Healthcare Market Forecast
  • Prescription Drug Market Forecast
  • Patented Drug Market Forecast
  • Generic Drug Market Forecast
  • OTC Medicine Market Forecast
  • Pharmaceutical Trade Forecast

Industry Risk/Reward Index

  • Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
  • Innovative Pharmaceuticals Risk/Reward Index

Regulatory Development

  • Regulatory Review

Market Overview

Competitive Landscape

Company Profile

  • Chemical Company Of Malaysia
  • Kotra Pharma
  • Novartis
  • Ranbaxy Malaysia
  • Sanofi

Malaysia Demographic Outlook

Pharmaceuticals & Healthcare Glossary

Back to Top